Viewing Study NCT00856492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2026-01-02 @ 4:09 AM
Study NCT ID: NCT00856492
Status: COMPLETED
Last Update Posted: 2017-06-27
First Post: 2009-03-04
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Sponsor: SWOG Cancer Research Network
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None inflammatory breast cancer View
None stage II breast cancer View
None stage IIIA breast cancer View
None stage IIIB breast cancer View
None HER2-negative breast cancer View
None estrogen receptor-negative breast cancer View
None estrogen receptor-positive breast cancer View
None progesterone receptor-negative breast cancer View
None progesterone receptor-positive breast cancer View
None stage IIIC breast cancer View